Development and validation of the angiotensin-converting enzyme inhibitor (ACEI) induced angioedema investigator rating scale and proposed discharge criteria

BACKGROUND: The use of angiotensin-converting enzyme inhibitors (ACEI) has been associated with the development of bradykinin-mediated angioedema. With ever-widening indications for ACEI in diseases including hypertension, congestive heart failure and diabetic nephropathy, a concomitant increase in...

Descripción completa

Detalles Bibliográficos
Autores principales: Bonner, Nicola, Panter, Charlotte, Kimura, Alan, Sinert, Rich, Moellman, Joseph, Bernstein, Jonathan A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5440910/
https://www.ncbi.nlm.nih.gov/pubmed/28532495
http://dx.doi.org/10.1186/s12913-017-2274-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5440910/
https://www.ncbi.nlm.nih.gov/pubmed/28532495
http://dx.doi.org/10.1186/s12913-017-2274-4

Ejemplares similares